A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jack Gilleland
| Share Statistics | BLRX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $14.0 | $292.6 | 8% |
|
| Shares Out (Mil) | 2,660.2 | 54.4 | 98% |
|
| Institutional Ownership | 91.8% | 93.2% | 60% |
|
| Float (Mil) | 2,508.3 | 40.2 | 96% |
|
| Beta | 0.62 | 0.94 | 36% |
|
| Avg Daily Volume (000s) | 8 | 544 | 16% |
|
| Price Change (52-week) |
(24.1%) | 59.7% | 26% |
|
| Growth | BLRX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.6% | na |
|
| Net Income (5yr) | 47.5% | (10.1%) | 93% |
|
| EPS (5yr) | 14.9% | 16.0% | 55 |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | (14.9%) | (15.6%) | 53% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | $0.000 | $0.000 | $0.000 | |
| Month Ago EPS | ($0.300) | ($0.930) | ($0.640) | |
| # Rev Up | 0 | 0 | 1 | |
| # Rev Down | 1 | 1 | 0 | |
| Three Months Ago EPS | ($0.320) | ($1.090) | ($0.670) | |
| Year/Year Chg | (100.0%) | na | na | |
| Financials | BLRX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1 | $37 | 3% |
|
| Net Income (TTM) (Mil) | ($8) | ($43) | 31% |
|
| EPS (TTM) | ($0.003) | ($1.400) | 39% |
|
| Operating Cash Flow (TTM) (Mil) | ($8) | ($31) | 22% |
|
| Net Cash Flow (TTM) (Mil) | ($7) | $2 | 33% |
|
| Long-Term Debt (Q1) (Mil) | $4 | $4 | 23% |
|
| Enterprise Value (Q1) (Mil) | $11 | $164 | 8% |
|
| Valuation | BLRX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 281.00 | 2.83 | 100% |
|
| P/E | na | 19.6 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | BLRX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 79.2% | 64.2% | 88% |
|
| Net Margin | (563.7%) | (75.9%) | 1% |
|
| ROA | (19.2%) | (47.5%) | 21% |
|
| ROE | (42.1%) | (55.0%) | 17% |
|
| Liabilities to Assets | 46.3% | 29.6% | 38% |
|
| F-Score | 3 | 3 | 18% |
|
BioLineRx Ltd. did not pass any screens on 8/21/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
